| Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure (NCT03128528) | University of Erlangen-Nürnberg Medical School | 2017-07-01 |
| Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer (NCT03188159) | National University Hospital, Singapore | 2017-07-01 |
| Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration (NCT03171818) | UMC Utrecht | 2017-07-01 |
| Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies (NCT03126968) | University of Maryland, Baltimore | 2017-07-01 |
| CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia (NCT04351022) | The First Affiliated Hospital of Soochow University | 2017-07-01 |
| Gain-framed Messages and NRT for Lung Cancer Screening Patients (NCT03069924) | Medical University of South Carolina | 2017-07-01 |
| Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients (NCT03066817) | New York City Health and Hospitals Corporation | 2017-07-01 |
| Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis (NCT03450083) | Johns Hopkins University | 2017-07-01 |
| Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer (NCT03001895) | Sir Mortimer B. Davis - Jewish General Hospital | 2017-07-01 |
| Combination of TATE and PD-1 Inhibitor in Liver Cancer (NCT03259867) | Teclison Ltd. | 2017-07-01 |
| Parkinson's Disease Therapy Using Cell Technology (NCT04146519) | Belarusian Medical Academy of Post-Graduate Education | 2017-07-01 |
| Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts (NCT04399577) | Zagazig University | 2017-07-01 |
| Vaginal Misoprostol In Management Of First Trimester Missed Abortion. (NCT03148314) | Assiut University | 2017-07-01 |
| A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. (NCT03210389) | Sun Yat-sen University | 2017-07-01 |
| Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT04884984) | The First Affiliated Hospital of Soochow University | 2017-07-01 |
| Oxytocin, Alcohol Craving, and Intimate Partner Aggression (NCT03046836) | Medical University of South Carolina | 2017-07-01 |
| The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer (NCT03202862) | Fudan University | 2017-07-01 |
| Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma (NCT03054532) | Singapore General Hospital | 2017-07-01 |
| Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer (NCT03950141) | Beijing Hospital | 2017-07-01 |
| Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy (NCT00737893) | Johns Hopkins University | 2017-07-01 |
| Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. (NCT03362814) | Ascletis Pharmaceuticals Co., Ltd. | 2017-07-01 |
| Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer (NCT03410732) | LanZhou University | 2017-07-01 |
| Basiliximab Treating Interstitial Pneumonia of CADM (NCT03192657) | RenJi Hospital | 2017-07-01 |
| Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer (NCT03300765) | Xiayun He, MD | 2017-07-01 |
| Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients (NCT03383315) | University of Malaya | 2017-07-01 |
| Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT03274011) | Fudan University | 2017-07-01 |
| Bandage Contact Lenses for Corneal Abrasions (NCT03206723) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2017-07-01 |
| Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD (NCT03170895) | The University of Hong Kong | 2017-07-01 |
| Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (NCT03192059) | University Hospital, Ghent | 2017-07-01 |
| Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer (NCT02907918) | Washington University School of Medicine | 2017-06-30 |
| Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome (NCT03226444) | TearSolutions, Inc. | 2017-06-30 |
| Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT03174197) | M.D. Anderson Cancer Center | 2017-06-30 |
| Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients (NCT03381118) | St. Petersburg State Pavlov Medical University | 2017-06-30 |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma (NCT03168061) | NanoCarrier Co., Ltd. | 2017-06-30 |
| Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma (NCT03145064) | BeiGene | 2017-06-30 |
| Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN (NCT03085719) | Dana-Farber Cancer Institute | 2017-06-30 |
| Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management (NCT03058614) | University of California, San Francisco | 2017-06-30 |
| A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies (NCT03191773) | Second Affiliated Hospital of Guangzhou Medical University | 2017-06-30 |
| Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA (NCT03453424) | South Egypt Cancer Institute | 2017-06-30 |
| Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb (NCT03183505) | Shanghai Mental Health Center | 2017-06-30 |
| Ruxolitinib In GvHD (NCT02396628) | Prof. Dr. Nikolas von Bubnoff | 2017-06-29 |
| Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation (NCT02953457) | Roswell Park Cancer Institute | 2017-06-29 |
| A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies (NCT03205046) | Acerta Pharma BV | 2017-06-29 |
| Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (NCT02929251) | Assistance Publique - Hôpitaux de Paris | 2017-06-29 |
| A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy (NCT03206749) | Vertex Pharmaceuticals Incorporated | 2017-06-29 |
| Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) (NCT04403399) | University of Michigan | 2017-06-29 |
| Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma (NCT03024437) | Roberto Pili | 2017-06-29 |
| Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC (NCT03041311) | G1 Therapeutics, Inc. | 2017-06-29 |
| PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy (NCT03132636) | Regeneron Pharmaceuticals | 2017-06-29 |
| Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) (NCT03180619) | Gilead Sciences | 2017-06-29 |
| Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction (NCT03198585) | Morten Schou | 2017-06-29 |
| Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC (NCT03025880) | Spanish Breast Cancer Research Group | 2017-06-28 |
| Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis (NCT03205345) | Conatus Pharmaceuticals Inc. | 2017-06-28 |
| Ruboxistaurin in New York Heart Failure Classification III-IV Patients (NCT02769611) | University of Tennessee | 2017-06-28 |
| Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy: (NCT03180632) | St. Justine's Hospital | 2017-06-28 |
| Octreotide LAR in the Induction of Immunologic Response in NENs Patients (NCT04129255) | National Cancer Institute, Naples | 2017-06-28 |
| Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC (NCT03184090) | MedSIR | 2017-06-28 |
| Platelet Rich Plasma (PRP) Peri-urethral and Clitoral Injections for the Treatment of Female Orgasmic Disorder (NCT03189238) | Center for Vulvovaginal Disorders | 2017-06-28 |
| The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence (NCT03209206) | Seoul National University Hospital | 2017-06-28 |
| PDL-1 Targeting in Resectable Oesophageal Cancer (NCT03087864) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2017-06-28 |
| Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease (NCT03036839) | Gilead Sciences | 2017-06-27 |
| Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea (NCT03185143) | Allodynic Therapeutics, Inc | 2017-06-27 |
| Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide (NCT03139851) | Centre Leon Berard | 2017-06-27 |
| Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer (NCT03107182) | University of Chicago | 2017-06-27 |
| Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma (NCT03278626) | NYU Langone Health | 2017-06-27 |
| Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy (NCT02795572) | AHS Cancer Control Alberta | 2017-06-27 |
| Budesonide for Liver Transplant Immune Suppression (NCT03304626) | University of Cincinnati | 2017-06-27 |
| Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (NCT03219320) | Aptinyx | 2017-06-27 |
| Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03685695) | Roswell Park Cancer Institute | 2017-06-27 |
| Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia (NCT02997761) | University of California, Davis | 2017-06-27 |
| Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN) (NCT03094195) | Novartis Pharmaceuticals | 2017-06-27 |
| Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery (NCT03147196) | Mayo Clinic | 2017-06-27 |
| A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression (NCT03228394) | Marinus Pharmaceuticals | 2017-06-27 |
| A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (NCT03100149) | Hoffmann-La Roche | 2017-06-27 |
| Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC (NCT03201146) | West China Hospital | 2017-06-27 |
| Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) (NCT02962895) | Novartis Pharmaceuticals | 2017-06-27 |
| Adult Study to Evaluate Placement of Tympanostomy Tubes In-office (ADEPT) (NCT03197558) | Tusker Medical | 2017-06-27 |
| A Study of ONO-7475 in Patients With Acute Leukemias (NCT03176277) | Ono Pharmaceutical Co., Ltd. | 2017-06-26 |
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer (NCT03110978) | M.D. Anderson Cancer Center | 2017-06-26 |
| Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues (NCT03204396) | University Hospital, Basel, Switzerland | 2017-06-26 |
| Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (NCT03161353) | MedSIR | 2017-06-26 |
| QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer (NCT03127098) | NantCell, Inc. | 2017-06-26 |
| Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma (NCT03108027) | Novartis Pharmaceuticals | 2017-06-26 |
| Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer (NCT03162224) | MedImmune LLC | 2017-06-26 |
| A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra (NCT03224598) | Aclaris Therapeutics, Inc. | 2017-06-26 |
| Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT03064867) | Molly Gallogly | 2017-06-26 |
| A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) (NCT03162536) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2017-06-26 |
| Effects of Erythropoietin for Cognitive Side-effects of ECT (NCT03339596) | Martin Balslev Jørgensen | 2017-06-26 |
| Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. (NCT03226067) | Calliditas Therapeutics AB | 2017-06-26 |
| PSMA PET Imaging of Recurrent Prostate Cancer (NCT03204123) | Memorial Sloan Kettering Cancer Center | 2017-06-26 |
| CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (NCT03289455) | Autolus Limited | 2017-06-26 |
| Blood Brain Barrier Opening in Alzheimer' Disease (NCT03119961) | Assistance Publique - Hôpitaux de Paris | 2017-06-26 |
| Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma (NCT03099265) | Yale University | 2017-06-26 |
| LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders (NCT03153579) | University Hospital, Basel, Switzerland | 2017-06-23 |
| A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations (NCT03226301) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2017-06-23 |
| Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02839707) | National Cancer Institute (NCI) | 2017-06-23 |
| A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer (NCT03093272) | Dana-Farber Cancer Institute | 2017-06-23 |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients (NCT03036930) | National Cancer Institute (NCI) | 2017-06-23 |
| Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer (NCT03043313) | Seagen Inc. | 2017-06-23 |
| Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer (NCT03112590) | H. Lee Moffitt Cancer Center and Research Institute | 2017-06-23 |